EMBC Insider Trading Activity and SEC Form 4 Filings
Trump's trades in EMBC
From his financial disclosures
$30K+
2 purchases
$31K+
3 sales
Sale
May 15, 2026
Reported 47d later
$1K - $15K
Purchase
Apr 30, 2026
Reported 62d later
$15K - $50K
Sale
Mar 30, 2026
Reported 45d later
$15K - $50K
Purchase
Feb 26, 2026
Reported 77d later
$15K - $50K
Sale
Jan 26, 2026
Reported 108d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
EMBC insider trading summary
Over the past 12 months, insiders at Embecta Corp. (EMBC) reported 4 open-market purchases worth $558K by 4 insiders and 1 sale worth $37K by 1 insider on SEC Form 4. Net insider buying was $521K.
Latest EMBC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Milton Mayo Morris | Director | Sell | $37K (6,293 @ $5.88) |
| Aug 12, 2026 | Devdatt Kurdikar | President and CEO | Buy | $141K (30,000 @ $4.70) |
| Aug 12, 2026 | Robert J. Hombach | Director | Buy | $224K (45,000 @ $4.97) |
| Aug 12, 2026 | Jacob Elguicze | SVP and CFO | Buy | $93K (20,000 @ $4.67) |
| Aug 12, 2026 | Jeffrey Z Mann | Pres, Pharm Svc&Prod Mgmt, CLO | Buy | $100K (20,000 @ $4.99) |
| May 23, 2025 | David F Melcher | Director | Buy | $106K (10,000 @ $10.60) |
| Feb 25, 2025 | David F Melcher | Director | Buy | $178K (13,000 @ $13.67) |
| Feb 13, 2025 | Milton Mayo Morris | Director | Sell | $51K (3,100 @ $16.38) |
| Feb 12, 2024 | David F Melcher | Director | Buy | $33K (2,000 @ $16.25) |
| Sep 8, 2023 | David F Melcher | Director | Buy | $98K (6,233 @ $15.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.